Sign up to save your podcasts
Or
Share The Choice of Neoadjuvant Therapy for Hormone Receptor Positive Breast Cancer
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Choice of Neoadjuvant Therapy for Hormone Receptor Positive Breast Cancer
In this episode of SurgOnc Today™, Armando Giuliano, MD, Tari King, MD and Otto Metzger, MD, discuss the choice between preoperative endocrine therapy and preoperative chemotherapy in hormone receptor positive breast cancer patients. Evaluation and treatment is discussed for a post-menopausal woman presenting a 3.4 cm node negative, invasive ductal carcinoma
View all episodes
By Society of Surgical Oncology
5
1111 ratings
In this episode of SurgOnc Today™, Armando Giuliano, MD, Tari King, MD and Otto Metzger, MD, discuss the choice between preoperative endocrine therapy and preoperative chemotherapy in hormone receptor positive breast cancer patients. Evaluation and treatment is discussed for a post-menopausal woman presenting a 3.4 cm node negative, invasive ductal carcinoma
More shows like SurgOnc Today®
View all
Freakonomics Radio
32,139 Listeners
Planet Money
30,648 Listeners
NEJM This Week
321 Listeners
JAMA Clinical Reviews
496 Listeners
Behind The Knife: The Surgery Podcast
1,315 Listeners
Pod Save America
87,379 Listeners
White Coat Investor Podcast
2,441 Listeners
The Daily
112,601 Listeners
Pod Save the World
24,684 Listeners
Up First from NPR
56,441 Listeners
Worklife with Adam Grant
9,184 Listeners
The Happiness Lab with Dr. Laurie Santos
14,384 Listeners
The AHPBA Podcast
9 Listeners
Consider This from NPR
6,371 Listeners
Good Inside with Dr. Becky
4,535 Listeners